Your browser doesn't support javascript.
loading
Expression of soluble CD27 in extranodal natural killer/T-cell lymphoma, nasal type: potential as a biomarker for diagnosis and CD27/CD70-targeted therapy.
Nagato, Toshihiro; Komatsuda, Hiroki; Hayashi, Ryusuke; Takahara, Miki; Kishibe, Kan; Yasuda, Shunsuke; Yajima, Yuki; Kosaka, Akemi; Ohkuri, Takayuki; Oikawa, Kensuke; Harabuchi, Shohei; Kono, Michihisa; Yamaki, Hidekiyo; Wakisaka, Risa; Hirata-Nozaki, Yui; Ohara, Kenzo; Kumai, Takumi; Katada, Akihiro; Hayashi, Tatsuya; Harabuchi, Yasuaki; Kobayashi, Hiroya.
Affiliation
  • Nagato T; Department of Pathology, Asahikawa Medical University, 2-1-1-1 Midorigaoka-Higashi, Asahikawa, 078-8510, Japan. rijun@asahikawa-med.ac.jp.
  • Komatsuda H; Department of Pathology, Asahikawa Medical University, 2-1-1-1 Midorigaoka-Higashi, Asahikawa, 078-8510, Japan.
  • Hayashi R; Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical University, Asahikawa, Japan.
  • Takahara M; Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical University, Asahikawa, Japan.
  • Kishibe K; Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical University, Asahikawa, Japan.
  • Yasuda S; Department of Innovative Research for Diagnosis and Treatment of Head and Neck Cancer, Asahikawa Medical University, Asahikawa, Japan.
  • Yajima Y; Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical University, Asahikawa, Japan.
  • Kosaka A; Department of Pathology, Asahikawa Medical University, 2-1-1-1 Midorigaoka-Higashi, Asahikawa, 078-8510, Japan.
  • Ohkuri T; Respiratory and Breast Center, Asahikawa Medical University Hospital, Asahikawa, Japan.
  • Oikawa K; Department of Pathology, Asahikawa Medical University, 2-1-1-1 Midorigaoka-Higashi, Asahikawa, 078-8510, Japan.
  • Harabuchi S; Department of Oral and Maxillofacial Surgery, Asahikawa Medical University, Asahikawa, Japan.
  • Kono M; Department of Pathology, Asahikawa Medical University, 2-1-1-1 Midorigaoka-Higashi, Asahikawa, 078-8510, Japan.
  • Yamaki H; Department of Pathology, Asahikawa Medical University, 2-1-1-1 Midorigaoka-Higashi, Asahikawa, 078-8510, Japan.
  • Wakisaka R; Department of Pathology, Asahikawa Medical University, 2-1-1-1 Midorigaoka-Higashi, Asahikawa, 078-8510, Japan.
  • Hirata-Nozaki Y; Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical University, Asahikawa, Japan.
  • Ohara K; Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical University, Asahikawa, Japan.
  • Kumai T; Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical University, Asahikawa, Japan.
  • Katada A; Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical University, Asahikawa, Japan.
  • Hayashi T; Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical University, Asahikawa, Japan.
  • Harabuchi Y; Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical University, Asahikawa, Japan.
  • Kobayashi H; Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical University, Asahikawa, Japan.
Cancer Immunol Immunother ; 72(7): 2087-2098, 2023 Jul.
Article in En | MEDLINE | ID: mdl-36811663

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, T-Cell / Epstein-Barr Virus Infections Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Cancer Immunol Immunother Journal subject: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Year: 2023 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, T-Cell / Epstein-Barr Virus Infections Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Cancer Immunol Immunother Journal subject: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Year: 2023 Document type: Article Affiliation country: Country of publication: